BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 34166916)

  • 1. Multiple myeloma driving factor WHSC1 is a transcription target of oncogene HMGA2 that facilitates colon cancer proliferation and metastasis.
    Liu HH; Lee CH; Hsieh YC; Hsu DW; Cho EC
    Biochem Biophys Res Commun; 2021 Aug; 567():183-189. PubMed ID: 34166916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WHSC1 promotes wnt/β-catenin signaling in a FoxM1-dependent manner facilitating proliferation, invasion and epithelial-mesenchymal transition in breast cancer.
    Zhang J; Lu J; Chen Y; Li H; Lin L
    J Recept Signal Transduct Res; 2020 Oct; 40(5):410-418. PubMed ID: 32314642
    [No Abstract]   [Full Text] [Related]  

  • 3. MicroRNA-204-3p represses colon cancer cells proliferation, migration, and invasion by targeting HMGA2.
    Xi X; Teng M; Zhang L; Xia L; Chen J; Cui Z
    J Cell Physiol; 2020 Feb; 235(2):1330-1338. PubMed ID: 31286521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMGA2 induces transcription factor Slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression.
    Li Y; Zhao Z; Xu C; Zhou Z; Zhu Z; You T
    Cancer Lett; 2014 Dec; 355(1):130-40. PubMed ID: 25218351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of Histone Methyltransferase WHSC1 Induces Apoptosis and Inhibits Cell Proliferation and Tumorigenesis in Salivary Adenoid Cystic Carcinoma.
    Liu C; Jiang YH; Zhao ZL; Wu HW; Zhang L; Yang Z; Hoffman RM; Zheng JW
    Anticancer Res; 2019 Jun; 39(6):2729-2737. PubMed ID: 31177108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The histone methyltransferase WHSC1 is regulated by EZH2 and is important for ovarian clear cell carcinoma cell proliferation.
    Kojima M; Sone K; Oda K; Hamamoto R; Kaneko S; Oki S; Kukita A; Machino H; Honjoh H; Kawata Y; Kashiyama T; Asada K; Tanikawa M; Mori-Uchino M; Tsuruga T; Nagasaka K; Matsumoto Y; Wada-Hiraike O; Osuga Y; Fujii T
    BMC Cancer; 2019 May; 19(1):455. PubMed ID: 31092221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WHSC1/NSD2 regulates immune infiltration in prostate cancer.
    Want MY; Tsuji T; Singh PK; Thorne JL; Matsuzaki J; Karasik E; Gillard B; Cortes Gomez E; Koya RC; Lugade A; Odunsi K; Battaglia S
    J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33589522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-543 suppresses colorectal cancer growth and metastasis by targeting KRAS, MTA1 and HMGA2.
    Fan C; Lin Y; Mao Y; Huang Z; Liu AY; Ma H; Yu D; Maitikabili A; Xiao H; Zhang C; Liu F; Luo Q; Ouyang G
    Oncotarget; 2016 Apr; 7(16):21825-39. PubMed ID: 26968810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-2392 suppresses metastasis and epithelial-mesenchymal transition by targeting
    Li J; Li T; Lu Y; Shen G; Guo H; Wu J; Lei C; Du F; Zhou F; Zhao X; Nie Y; Fan D
    FASEB J; 2017 Sep; 31(9):3774-3786. PubMed ID: 28512191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic activation of WHSC1 functions as an oncogene and is associated with poor prognosis in cervical cancer.
    Yin Z; Sun Y; Ge S; Sun J
    Oncol Rep; 2017 Apr; 37(4):2286-2294. PubMed ID: 28260054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of microRNA-154 targeting WHSC1 on cell proliferation of human skin squamous cell carcinoma through mediating the P53 signaling pathway.
    Chen HQ; Gao D
    Int J Biochem Cell Biol; 2018 Jul; 100():22-29. PubMed ID: 29727714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NSD2 is recruited through its PHD domain to oncogenic gene loci to drive multiple myeloma.
    Huang Z; Wu H; Chuai S; Xu F; Yan F; Englund N; Wang Z; Zhang H; Fang M; Wang Y; Gu J; Zhang M; Yang T; Zhao K; Yu Y; Dai J; Yi W; Zhou S; Li Q; Wu J; Liu J; Wu X; Chan H; Lu C; Atadja P; Li E; Wang Y; Hu M
    Cancer Res; 2013 Oct; 73(20):6277-88. PubMed ID: 23980095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AKT-mediated stabilization of histone methyltransferase WHSC1 promotes prostate cancer metastasis.
    Li N; Xue W; Yuan H; Dong B; Ding Y; Liu Y; Jiang M; Kan S; Sun T; Ren J; Pan Q; Li X; Zhang P; Hu G; Wang Y; Wang X; Li Q; Qin J
    J Clin Invest; 2017 Apr; 127(4):1284-1302. PubMed ID: 28319045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dicoumarol suppresses HMGA2-mediated oncogenic capacities and inhibits cell proliferation by inducing apoptosis in colon cancer.
    Chen CH; Hsieh YC; Yang PM; Liu YR; Cho EC
    Biochem Biophys Res Commun; 2020 Apr; 524(4):1003-1009. PubMed ID: 32063361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The histone methyltransferase MMSET/WHSC1 activates TWIST1 to promote an epithelial-mesenchymal transition and invasive properties of prostate cancer.
    Ezponda T; Popovic R; Shah MY; Martinez-Garcia E; Zheng Y; Min DJ; Will C; Neri A; Kelleher NL; Yu J; Licht JD
    Oncogene; 2013 Jun; 32(23):2882-90. PubMed ID: 22797064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing miR-150 and lowering HMGA2 inhibit proliferation and cycle progression of colon cancer in SW480 cells.
    Zhang ZC; Wang GP; Yin LM; Li M; Wu LL
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6793-6800. PubMed ID: 30402842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WHSC1 promotes oncogenesis through regulation of NIMA-related kinase-7 in squamous cell carcinoma of the head and neck.
    Saloura V; Cho HS; Kiyotani K; Alachkar H; Zuo Z; Nakakido M; Tsunoda T; Seiwert T; Lingen M; Licht J; Nakamura Y; Hamamoto R
    Mol Cancer Res; 2015 Feb; 13(2):293-304. PubMed ID: 25280969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E2F2 induces MCM4, CCNE2 and WHSC1 upregulation in ovarian cancer and predicts poor overall survival.
    Xie L; Li T; Yang LH
    Eur Rev Med Pharmacol Sci; 2017 May; 21(9):2150-2156. PubMed ID: 28537669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of HMGA2 promotes apoptosis and inhibits migration and invasion of prostate cancer cells.
    Shi Z; Wu D; Tang R; Li X; Chen R; Xue S; Zhang C; Sun X
    J Biosci; 2016 Jun; 41(2):229-36. PubMed ID: 27240983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing of HMGA2 suppresses cellular proliferation, migration, invasion, and epithelial-mesenchymal transition in bladder cancer.
    Shi Z; Li X; Wu D; Tang R; Chen R; Xue S; Sun X
    Tumour Biol; 2016 Jun; 37(6):7515-23. PubMed ID: 26684800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.